TERRASCEND CORP (TSND.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:TSND - CA88105E1088 - Common Stock
0.7 CAD
+0.03 (+4.48%)
We assign a fundamental rating of 3 out of 10 to TSND. TSND was compared to 31 industry peers in the Pharmaceuticals industry. TSND may be in some trouble as it scores bad on both profitability and health. TSND is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TSND has reported negative net income.
TSND had a positive operating cash flow in the past year.
TSND had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TSND reported negative operating cash flow in multiple years.
1.2 Ratios
TSND has a worse Return On Assets (-21.71%) than 67.74% of its industry peers.
The Return On Equity of TSND (-128.44%) is worse than 74.19% of its industry peers.
With an excellent Return On Invested Capital value of 5.70%, TSND belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.71% | ||
| ROE | -128.44% | ||
| ROIC | 5.7% |
ROA(3y)-24.86%
ROA(5y)-21.32%
ROE(3y)-62.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TSND has a better Operating Margin (13.76%) than 80.65% of its industry peers.
In the last couple of years the Operating Margin of TSND has declined.
TSND has a Gross Margin of 51.29%. This is in the better half of the industry: TSND outperforms 74.19% of its industry peers.
In the last couple of years the Gross Margin of TSND has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | N/A | ||
| GM | 51.29% |
OM growth 3Y-5.82%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.82%
GM growth 5Y37.79%
2. Health
2.1 Basic Checks
TSND has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TSND has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TSND has more shares outstanding
TSND has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -1.14, we must say that TSND is in the distress zone and has some risk of bankruptcy.
TSND has a Altman-Z score of -1.14. This is in the lower half of the industry: TSND underperforms 61.29% of its industry peers.
TSND has a debt to FCF ratio of 22.68. This is a negative value and a sign of low solvency as TSND would need 22.68 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 22.68, TSND is doing good in the industry, outperforming 61.29% of the companies in the same industry.
A Debt/Equity ratio of 2.26 is on the high side and indicates that TSND has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.26, TSND is doing worse than 80.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.26 | ||
| Debt/FCF | 22.68 | ||
| Altman-Z | -1.14 |
ROIC/WACC0.58
WACC9.87%
2.3 Liquidity
A Current Ratio of 1.56 indicates that TSND should not have too much problems paying its short term obligations.
TSND has a Current ratio (1.56) which is in line with its industry peers.
TSND has a Quick Ratio of 1.12. This is a normal value and indicates that TSND is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.12, TSND perfoms like the industry average, outperforming 45.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
TSND shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.00%.
The Revenue for TSND has decreased by -13.62% in the past year. This is quite bad
Measured over the past years, TSND shows a very strong growth in Revenue. The Revenue has been growing by 36.80% on average per year.
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)-13.62%
Revenue growth 3Y13.38%
Revenue growth 5Y36.8%
Sales Q2Q%-12.22%
3.2 Future
Based on estimates for the next years, TSND will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.08% on average per year.
Based on estimates for the next years, TSND will show a small growth in Revenue. The Revenue will grow by 0.62% on average per year.
EPS Next Y33.89%
EPS Next 2Y33.17%
EPS Next 3Y23.15%
EPS Next 5Y13.08%
Revenue Next Year-14.01%
Revenue Next 2Y-6.2%
Revenue Next 3Y-2.44%
Revenue Next 5Y0.62%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
TSND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSND. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TSND is valued cheaply inside the industry as 87.10% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, TSND is valued a bit cheaper than 64.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19 | ||
| EV/EBITDA | 6.56 |
4.3 Compensation for Growth
TSND's earnings are expected to grow with 23.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.17%
EPS Next 3Y23.15%
5. Dividend
5.1 Amount
No dividends for TSND!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:TSND (12/9/2025, 7:00:00 PM)
0.7
+0.03 (+4.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners38.98%
Inst Owner ChangeN/A
Ins Owners5.75%
Ins Owner ChangeN/A
Market Cap257.77M
Revenue(TTM)275.46M
Net Income(TTM)-120.56M
Analysts82.22
Price Target1.79 (155.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-481.28%
Min EPS beat(2)-614.39%
Max EPS beat(2)-348.18%
EPS beat(4)0
Avg EPS beat(4)-310.68%
Min EPS beat(4)-614.39%
Max EPS beat(4)-20.66%
EPS beat(8)0
Avg EPS beat(8)-308.43%
EPS beat(12)1
Avg EPS beat(12)-207.87%
EPS beat(16)2
Avg EPS beat(16)-327.17%
Revenue beat(2)0
Avg Revenue beat(2)-4.75%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-3.35%
Revenue beat(4)0
Avg Revenue beat(4)-3.84%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)-2.6%
Revenue beat(8)0
Avg Revenue beat(8)-4.34%
Revenue beat(12)2
Avg Revenue beat(12)-3.04%
Revenue beat(16)2
Avg Revenue beat(16)-5.41%
PT rev (1m)-8.7%
PT rev (3m)-6.67%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)55.01%
EPS NY rev (1m)-48.94%
EPS NY rev (3m)-52.17%
Revenue NQ rev (1m)-1.5%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)-0.64%
Revenue NY rev (3m)-0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | 19 | ||
| P/OCF | 8.03 | ||
| P/B | 1.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.56 |
EPS(TTM)-0.55
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.04
FCFY5.26%
OCF(TTM)0.09
OCFY12.46%
SpS1.03
BVpS0.35
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.71% | ||
| ROE | -128.44% | ||
| ROCE | 7.91% | ||
| ROIC | 5.7% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 17.05% | ||
| OM | 13.76% | ||
| PM (TTM) | N/A | ||
| GM | 51.29% | ||
| FCFM | 3.57% |
ROA(3y)-24.86%
ROA(5y)-21.32%
ROE(3y)-62.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-2.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y1.66%
ROICexc growth 5YN/A
OM growth 3Y-5.82%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.82%
GM growth 5Y37.79%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.26 | ||
| Debt/FCF | 22.68 | ||
| Debt/EBITDA | 3.83 | ||
| Cap/Depr | 77.06% | ||
| Cap/Sales | 4.88% | ||
| Interest Coverage | 1.43 | ||
| Cash Conversion | 42.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | -1.14 |
F-Score6
WACC9.87%
ROIC/WACC0.58
Cap/Depr(3y)90.87%
Cap/Depr(5y)192.32%
Cap/Sales(3y)7.77%
Cap/Sales(5y)14.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y33.89%
EPS Next 2Y33.17%
EPS Next 3Y23.15%
EPS Next 5Y13.08%
Revenue 1Y (TTM)-13.62%
Revenue growth 3Y13.38%
Revenue growth 5Y36.8%
Sales Q2Q%-12.22%
Revenue Next Year-14.01%
Revenue Next 2Y-6.2%
Revenue Next 3Y-2.44%
Revenue Next 5Y0.62%
EBIT growth 1Y14.74%
EBIT growth 3Y6.79%
EBIT growth 5YN/A
EBIT Next Year159.57%
EBIT Next 3Y41.98%
EBIT Next 5Y29.27%
FCF growth 1Y227.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.28%
OCF growth 3YN/A
OCF growth 5YN/A
TERRASCEND CORP / TSND.CA FAQ
What is the fundamental rating for TSND stock?
ChartMill assigns a fundamental rating of 3 / 10 to TSND.CA.
What is the valuation status for TSND stock?
ChartMill assigns a valuation rating of 2 / 10 to TERRASCEND CORP (TSND.CA). This can be considered as Overvalued.
What is the profitability of TSND stock?
TERRASCEND CORP (TSND.CA) has a profitability rating of 3 / 10.
What is the financial health of TERRASCEND CORP (TSND.CA) stock?
The financial health rating of TERRASCEND CORP (TSND.CA) is 2 / 10.